
Ruella Lab
@ruellalab
We focus on mechanisms of relapse after CAR-T therapy. Our goal is to design innovative combined IMT for relapsing/refractory Leukemia & Lymphoma. @MarcoRuella
ID: 1210594006641651715
https://www.med.upenn.edu/cci/ruellalab/ 27-12-2019 16:12:27
5 Tweet
144 Followers
11 Following